NCT01743482View on ClinicalTrials.gov

Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

May 17, 2013

Primary Completion Date

July 27, 2016

Study Completion Date

July 27, 2016

Conditions

Germ Cell TumorsMeasurable Disease

Interventions

DRUG

Pazopanib

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT01743482 - Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors | Biotech Hunter | Biotech Hunter